The Global Transcatheter Cardiac Valve Replacement (THVR) Market, valued at USD 6.54 billion in 2023, is anticipated to grow significantly with a CAGR of 14.8% over the forecast period of 2024 to 2032 ...
The recent significant penalty imposed on Medtronic sends a strong warning to companies supplying therapeutic goods in Australia. It reinforces the central position of the Australian Register of ...
Medtronic plc has announced United States Food and Drug Administration (FDA) approval of the Affera Mapping and Ablation ...
Surface, who reported to CEO Tim Cook, joined Apple in early 2023 from Medtronic, where she spent nearly a decade as executive vice president and chief human resources officer. Part of her role was to ...
The Affera mapping and ablation system is the first on the market that can deliver both pulsed-field and radiofrequency ...
Queensland became Australia’s first mainland state to elect a center-right government in more than 18 months, breaking the Labor Party’s hold on power ahead of a national election due by May.
Medtronic MDT underwent analysis by 15 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table provides a quick overview of their recent ...
This approval is expected to help in treatment of persistent AFib and for RF ablation of CTI dependent atrial flutter.
The Affera mapping and ablation system and Sphere-9 catheter also got CE Mark approval in March 2023 and were authorised for use in Australia last month. This month, Medtronic announced the ...
"This marks an exciting milestone for the field, with Medtronic's robust innovation pipeline poised to drive continued progress." "At Medtronic, we have a 75-year tradition of bringing disruptive ...
Medtronic PLC (NYSE:MDT), a global leader in medical technology, services, and solutions, has been navigating a complex landscape of opportunities and challenges. Recent analyst reports and financial ...